From putting off regularly scheduled facility audits and waiving preapproval inspections, to allowing more leeway for 30-day notices and pre-market submissions, US FDA wants to hand a huge gift basket to medical device-makers that voluntarily play in an upcoming pilot program.
The pilot, which aims to determine the manufacturing maturity of firms, will be stood up in early 2018. Manufacturers that take part would use a specified maturity model and work with third-party assessors to measure their quality systems and manufacturing processes
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?